We are Antioxidant 703 CAS:88-27-7 manufacturer and supplier in China, Pls send inquiry of to email@example.com of visit www.nbinno.com our official website should you have any interests
SPECIFICATIONS AND PHYSICAL CHARACTERISTICS
PRODUCT FEATURES AND APPLICATIONS
ANTIOXIDANT AN 703 is highly effective non-discoloring non-polluting antioxidant for lubricating oil mineral oilrubber and plastic.
ANTIOXIDANT AN 703 has good compatability with most resins and excellent thermal stability.
ANTIOXIDANT AN 703 is mainly used in lubricating oil mineral oilnatural synthetic latex polyolefin polyesterand cellulose plastic.
HANDLING AND STORAGE
Keep container tightly closed and dry and storage in cool place
Related News: With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow.3(2H)-Pyridazinone, 5-(2-bromoethoxy)-4-chloro-2-(1,1-dimethylethyl)- How can I protect myself? Take the same precautionary measures you would during flu season. Wash your hands often with soap and water, cover your nose and mouth when you sneeze or cough, avoid close contact with people or large gatherings, and wear a face mask.26661-13-2 If an API is not ultrapure, a medicine cannot meet the strict quality criteria so the quality of an API plays a very important role.3-Fluoro-4-methoxyacetophenone CAS:455-91-4 At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.